Other

CN code 300449 covers other medicines containing alkaloids or their derivatives, put up in measured doses or in forms for retail sale, not classified under other subheadings of heading 3004. This heading is residual in relation to more specific subheadings for alkaloid medicines. Products classified here include finished medicines in the form of tablets, capsules, syrups, drops, ointments, suppositories, and injection solutions containing alkaloids such as papaverine, theophylline, ephedrine, ergotamine, colchicine, berberine, or their synthetic derivatives. Multi-component products containing alkaloids combined with other active substances (such as analgesic preparations with codeine and paracetamol) may be classified under this code, provided the alkaloid constitutes a significant active ingredient. The key criterion is the product's presentation in retail doses.

Medicines containing alkaloids packaged in doses are subject to varying levels of control depending on the nature of the alkaloid active substance. Medicines containing controlled substances (such as codeine, dihydrocodeine, ephedrine above certain thresholds) require a narcotic or psychotropic substance import permit. Medicines with alkaloids not subject to narcotic controls (such as papaverine, theophylline, colchicine) are subject to standard pharmaceutical requirements: marketing authorisation (MA), manufacturer's GMP certificate, and GDP principles in distribution. Directive 2011/62/EU mandates serialisation of prescription medicine packaging. The importer must hold a pharmaceutical wholesale distribution authorisation. Medicines containing ephedrine or pseudoephedrine are additionally controlled as drug precursors under Regulation (EC) No 273/2004.

At customs clearance for medicines under CN code 300449, the marketing authorisation, manufacturer's GMP certificate, Certificate of Analysis (CoA), and serialisation documentation (for prescription medicines) must be presented. For medicines with controlled substances, a narcotic or psychotropic import permit is additionally required, and imported quantities must be verified against allocated limits. Transport of alkaloid medicines follows standard GDP requirements - most products require controlled room temperature storage (15 to 25 degrees Celsius) with protection from light and moisture. Duty rates should be checked in TARIC or ISZTAR, taking into account any autonomous duty suspensions. The importer should ensure that the product packaging includes labelling and a patient information leaflet in the local language in compliance with Directive 2001/83/EC requirements.

Importing pharmaceutical products under CN code 3004 49 (Other alkaloid medicines in doses) requires authorisation from the national medicines agency. All medicines placed on the EU market must hold a marketing authorisation issued by EMA (centralised procedure) or a national authority. Compliance with Good Manufacturing Practice (GMP) confirmed by a certificate is mandatory. Biological products require cold chain maintenance. Serialisation and authenticity verification (FMD 2011/62/EU) are mandatory for prescription medicines.